Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Arteriolar smooth muscle refers to the specialized smooth muscle cells in the walls of arterioles. Direct relaxation of these muscles leads to vasodilation, increasing vessel diameter and reducing vascular resistance. This process is critical for regulating blood flow, blood pressure, and tissue perfusion. It involves complex calcium dynamics, myosin light chain phosphatase activation, and endothelial-derived factors like nitric oxide. Dysfunction in this system contributes to several cardiovascular diseases, making it a therapeutic target.
Direct relaxation of arteriolar smooth muscle leads to vasodilation by decreasing intracellular calcium concentration, activating myosin light chain phosphatase, and/or through endothelial factors like nitric oxide (NO) that increase cGMP levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arteriolar Smooth Muscle (Direct Relaxation) (ASM (Direct Relaxation)).